Home > Insider Trading > Filing (0001093557-14-000076)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1343856	A Jorge Valdes	6340 Sequence Drive San Diego CA 92121	Cto	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-03-08	71,000	$0.00	215,853	No	4	A	Direct
Common Stock	Acquisiton	2014-03-10	16,000	$3.19	231,853	No	4	M	Direct
Common Stock	Disposition	2014-03-10	16,000	$46.57	215,853	No	4	S	Direct
Common Stock	Disposition	2014-03-11	12,850	$46.10	203,003	No	4	D	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct
No	4	D	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2014-03-10	16,000	$46.57	16,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
97,000	2009-12-11	2018-12-11	No	4	M	Direct

Footnotes

Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting over a 36 month period from the date of grant as follows: 1/3 shall vest 12 months from the Grant Date, and the remaining balance shall vest in four equal installments over the following 24 months. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
Included in this number are 142,621 unvested restricted stock units, 71,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 47,747 of which were granted on March 11, 2013 and shall vest through March 11, 2016, and 23,874 of which were granted on March 8, 2012 and shall vest through March 8, 2015.
On November 15, 2013, Mr. Valdes adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Valdes. The shares set forth above were sold pursuant to the 10b5-1 Plan.
These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
Conversion or exercise price of derivative security is $3.19.